tiprankstipranks
Catalyst Pharma (CPRX)
NASDAQ:CPRX
Holding CPRX?
Track your performance easily

Catalyst Pharma (CPRX) Financial Statements

2,146 Followers

Catalyst Pharma Financial Overview

Catalyst Pharma's market cap is currently ―. The company's EPS TTM is $1.172; its P/E ratio is 18.15; Catalyst Pharma is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $0.34. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 128.69M$ 122.71M$ 98.51M$ 110.57M$ 102.69M
Gross Profit$ 109.42M$ 107.31M$ 85.99M$ 94.76M$ 88.52M
EBIT$ 57.20M$ 55.79M$ 38.43M$ 41.69M$ -37.19M
EBITDA$ 66.66M$ 65.22M$ 47.86M$ 50.84M$ -28.62M
Net Income Common Stockholders$ 43.88M$ 40.79M$ 23.27M$ 34.84M$ -30.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 442.33M$ 375.69M$ 310.41M$ 137.64M$ 120.97M
Total Assets$ 772.01M$ 706.36M$ 646.68M$ 470.11M$ 413.21M
Total Debt$ 2.89M$ 2.99M$ 3.09M$ 3.19M$ 3.28M
Net Debt$ -439.44M$ -372.70M$ -307.32M$ -134.45M$ -117.69M
Total Liabilities$ 111.07M$ 97.70M$ 85.26M$ 82.23M$ 64.66M
Stockholders Equity$ 660.94M$ 608.65M$ 561.41M$ 387.88M$ 348.55M
Cash Flow-
Free Cash Flow$ 72.61M$ 64.13M$ 31.73M$ 53.33M$ -34.22M
Operating Cash Flow$ 72.87M$ 64.14M$ 31.93M$ 55.65M$ 45.13M
Investing Cash Flow$ -259.00K$ -10.00K$ -199.00K$ -38.32M$ -92.82M
Financing Cash Flow$ -5.97M$ 1.16M$ 141.05M$ -665.00K$ -10.13M
Currency in USD

Catalyst Pharma Earnings and Revenue History

Catalyst Pharma Debt to Assets

Catalyst Pharma Cash Flow

Catalyst Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis